Similarly, the severe, late-onset eosinophilic asthma endotype, representing 20% of the severe asthma population [91], also shows features of TGFβ1 mediated EMT and airway remodeling in spite of good response to systemic corticosteroid therapy. This evidence concerns the gene TGFB1 and asthma.